We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for Pharmaceuticals.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

Pharmaceuticals Product List and Ranking from 19 Manufacturers, Suppliers and Companies

Last Updated： Aggregation Period:Sep 17, 2025～Oct 14, 2025
This ranking is based on the number of page views on our site.

Pharmaceuticals Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Sep 17, 2025～Oct 14, 2025
This ranking is based on the number of page views on our site.

  1. TECHNICAL INFOMATION INSTITUTE CO.,LTD Tokyo//Service Industry
  2. 関東化学株式会社 バイオケミカル部 Tokyo//Chemical
  3. Kaminashi inc. Tokyo//Information and Communications
  4. 4 岩城製薬 東日本ファインケミカル営業部 Tokyo//others
  5. 5 AndTech Kanagawa//Service Industry
Go to Company Ranking

Pharmaceuticals Product ranking

Last Updated： Aggregation Period:Sep 17, 2025～Oct 14, 2025
This ranking is based on the number of page views on our site.

  1. Business Introduction of the Technical Information Association, Inc. TECHNICAL INFOMATION INSTITUTE CO.,LTD
  2. Japanese Pharmacopoeia (Manufacturing Only) Pharmaceuticals 関東化学株式会社 バイオケミカル部
  3. What is GMP? A clear introduction to its differences from ordinances and ISO, as well as the three principles. Kaminashi inc.
  4. 4 Iwaki Pharmaceutical Co., Ltd. Business Introduction 岩城製薬 東日本ファインケミカル営業部
  5. 5 Trends in the Generic Pharmaceutical Industry and Basic Knowledge of Patents and Patent Strategies AndTech

Pharmaceuticals Product List

16～30 item / All 41 items

Displayed results
Introduction to the Seranostics Business

Introduction to the Seranostics Business

We would like to introduce a project aimed at the integration of imaging diagnosis and treatment using radiopharmaceuticals!

Theranostics, which closely links treatment and diagnosis, is expected to contribute to personalized medicine and the effective use of healthcare costs. By developing therapeutic agents using radioisotopes (RI: radioactive isotopes) that emit alpha particles, a type of radiation, along with companion diagnostic agents, we aim to realize theranostics. We have completed the CRADLE building and established the "Theranostics Production Technology Center." By placing a dedicated department, we will achieve the early supply of alpha-emitting radionuclides from the CRADLE building, while further strengthening collaboration between the drug discovery laboratory located within the same facility and the Chiba factory, thereby accelerating the development of theranostics drug discovery. 【Functions of the facility】 ■ Production of 225Ac and PET radionuclides ■ Handling of 177Lu and 211At, among others ■ Production of investigational drugs ■ Production of research-use RIs *For more details, please refer to the PDF document or feel free to contact us.

  • Other contract manufacturing
  • Other contract services
  • Pharmaceutical intermediate manufacturing services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Features of Aptamers

Features of Aptamers

Fits the shape of proteins! Nucleic acid molecules that can inhibit or regulate.

We would like to introduce the features of the "aptamer" that we handle. Single-stranded nucleic acids form various three-dimensional structures according to their sequences. Utilizing this structural capability, these nucleic acid molecules can bind to target proteins and inhibit or regulate their functions. Please feel free to contact us when you need assistance. 【Features】 ■ Creates a three-dimensional structure that fits the shape of the protein for binding, known as "shape capture." *For more details, please refer to the PDF materials or feel free to contact us.

  • Pharmaceutical Intermediates

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Examples of Analytical Methods in Biologics/Antibody Pharmaceuticals Held on February 16

Examples of Analytical Methods in Biologics/Antibody Pharmaceuticals Held on February 16

Introduction to analytical methods used for quality control of antibody pharmaceuticals! Online seminar introduction.

We are pleased to announce that our company will be hosting the third installment of our webinar series titled "Case Studies of Analytical Methods in Biologics/Antibody Drugs." In light of the growing development of biopharmaceuticals, our company has been strengthening its biopharmaceutical development capabilities. During this time, we have received numerous analytical project requests from our customers. In this webinar, we will introduce analytical methods used for quality control, using antibody drugs as examples, based on the knowledge we have cultivated thus far. We sincerely look forward to your participation. 【Overview】 ■ Date and Time: February 16 (Thursday) 11:00 AM - 11:30 AM ■ Format: Online (Teams) ■ Participation: Free *For more details, please refer to the related links or feel free to contact us.

  • Seminar

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Reagents, scientific instruments, pharmaceuticals

Reagents, scientific instruments, pharmaceuticals

Leave it to us for products related to research and development, including bio, genome, nanotechnology, with a core focus on reagent sales.

Our company has been providing products such as reagents, clinical testing agents, industrial chemicals, and scientific instruments to contribute to various users, including academic research institutions, industrial sectors, and the medical field, as a comprehensive reagent dealer. As a support industry for research and development, we will respond to advancements in science and technology and technological innovation by providing the information our customers seek and promoting proposal-based sales. Please feel free to contact us with any requests. 【Business Areas】 ■ Bio ■ Chemical ■ Clinical Testing ■ Quality Control and Analysis *For more details, please download the PDF or feel free to contact us.

  • Other contract services
  • Clinical Development Systems

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Molecular basis of small nucleic acids that control gene expression and their application in pharmaceuticals.

Molecular basis of small nucleic acids that control gene expression and their application in pharmaceuticals.

Keywords: microRNA, viral defense mechanisms, cell death due to viral infection, siRNA, nucleic acid medicines

mRNA is RNA that contains information for protein synthesis, but there are also many non-coding RNAs in the cell that do not carry messages. We have been elucidating the mechanisms by which immune responses to RNA virus infections are regulated by small non-coding RNAs called microRNAs. Understanding this mechanism may contribute to the development of novel nucleic acid medicines. Additionally, while siRNA also suppresses the expression of mRNA, siRNA has a suppressive effect on a single gene, whereas microRNA acts on entire specific gene groups. Although there are currently no nucleic acid medicines utilizing microRNA, we are hopeful that if the mechanisms of their action in virus-infected cells are clarified, the potential for nucleic acid medicines will expand even further.

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Techniques for Differentiating Strong Patent Specifications and Claims for Antibody Pharmaceutical Patents

Techniques for Differentiating Strong Patent Specifications and Claims for Antibody Pharmaceutical Patents

Which is advantageous for identification: antigen, CDR, cross-reactivity, or hybridoma?

★What constitutes a strong patent specification and claims when acquiring rights for antibody drugs? ★Along with essential practical knowledge, we will teach you claim techniques that your company may not know, incorporating exercises! 【Instructor】Akihiko Okuno, Representative Employee, SK Patent Firm, Patent Attorney 【Venue】Tekuno Kawasaki, 5th Floor, Room 5 Training 【Kanagawa, Musashi-Mizonokuchi Station】 【Date and Time】November 29, 2010 (Monday) 13:00–16:00 【Lecture ends at 16:00. 16:00-16:30: Free Time Q&A】

  • Company：AndTech
  • Price：10,000 yen-100,000 yen
  • Technical Seminar

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Trends in the Generic Pharmaceutical Industry and Basic Knowledge of Patents and Patent Strategies

Trends in the Generic Pharmaceutical Industry and Basic Knowledge of Patents and Patent Strategies

★Utilizing patents as a means of differentiation for generic pharmaceuticals! ★What is your perspective on the invalidation trials conducted by generic pharmaceutical companies as a business strategy?

Speaker Mr. Ichiro Tasaka, Patent Attorney, Nagasawa Patent Office/Tokyo Marunouchi Law Office Target Audience: Engineers and researchers interested in generic development strategies, patent analysis methods, etc. Venue RYUKA Intellectual Property Hall, 22F Seminar Room [Tokyo, Shinjuku] 3-minute walk from "Shinjuku" Station on JR, Odakyu Odawara Line, Keio Line, and Tokyo Metro Marunouchi Line Date and Time November 21, 2011 (Monday) 13:30-16:30 Capacity: 30 people *Registration will close once full. Please apply early. Participation Fee [Early Bird Discount Price] 19,950 yen per person (including tax and textbook fee) *Limited to Tech-Zone members who apply by November 7. Membership registration is free. *After November 7, the [Regular Price] will be 23,100 yen per person (including tax and textbook fee).

  • Company：AndTech
  • Price：10,000 yen-100,000 yen
  • Technical Seminar

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
【Industry-Specific Utilization Methods】Pharmaceuticals

【Industry-Specific Utilization Methods】Pharmaceuticals

We are introducing the three key points of GDP and two transportation methods corresponding to GDP!

In the pharmaceutical industry, it has become necessary to respond to GDP (Good Distribution Practice), which expands to include storage and transportation in the distribution process, as a complement to the conventional GMP (Good Manufacturing Practice) standards for manufacturing and quality control. Emphasis is placed on ensuring quality throughout the distribution process, with particular importance placed on temperature control. It is required that proper temperature management is maintained from the time products leave the manufacturing facility until they reach the patient. Wacon will assist you in complying with GDP using refrigerated boxes. *For more detailed information, please refer to the related links. For further details, you can download the PDF or feel free to contact us.*

  • Food transport materials (cooling, heat retention, etc.)

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
Web Seminar: Characterization of Antibody-Related Pharmaceuticals

Web Seminar: Characterization of Antibody-Related Pharmaceuticals

Toray Research Center × SciEx × Protein Metrics Jointly Hosted Web Seminar (Characterization of Antibody-Related Pharmaceuticals)

Analysis of the Characteristics of Antibody-Related Pharmaceuticals – Detailed Modification Analysis Including Charge Variants and Glycans Using LC-MS and icIEF-UV/MS – < Event Overview > Date and Time: January 16, 2025 (Thursday) 15:00 - 16:00 Format: Online (Zoom) 1. Analysis of Charge Heterogeneity of Antibody-Related Pharmaceuticals Using the Intabio ZT System (Ryo Yokoyama, AB Sciex Co., Ltd.) 2. Case Studies of Characteristic Analysis of Biopharmaceuticals Using Mass Spectrometry (Satoko Ota, Toray Research Center, Inc.) 3. Improving Work Efficiency in Protein Pharmaceutical Analysis Using MS Data Analysis Software Byos (Ayako Kurimoto, Protein Metrics) ◆ Detailed Page for This Webinar https://proteinmetrics.com/%e6%8a%97%e4%bd%93%e9%96%a2%e9%80%a3%e5%8c%bb%e8%96%ac%e5%93%81%e3%81%ae%e7%89%b9%e6%80%a7%e8%a7%a3%e6%9e%90/

  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Service Example] Major Pharmaceutical Company J

[Service Example] Major Pharmaceutical Company J

We will introduce examples of providing extensive support for the preparation of materials for internal controls and lectures for stakeholders, as well as support for the internal implementation of new business launches!

We would like to introduce a case where comprehensive project management was implemented for Company J, a major pharmaceutical company, while considering the legal regulations surrounding pharmaceutical sales. The company was exploring the launch of a new e-commerce platform in order to broaden its user base and achieve further sales growth. After the service was introduced, the synchronization of member information registered on the existing site with the e-commerce system was addressed, allowing purchasing behavior on the e-commerce platform to be reflected in the existing customer database in real-time. We provided extensive support for necessary e-commerce operations both before and after the release. [Challenges] - The company was exploring the launch of a new e-commerce platform to broaden its user base and achieve further sales growth. - There were several concerns regarding the construction of the e-commerce platform, including the specific regulations of the Pharmaceutical and Medical Device Act (formerly the Pharmaceutical Affairs Law) related to pharmaceutical e-commerce and the integration of member information registered on the existing site. *For more details, please refer to the related links or feel free to contact us.*

  • Internal Control and Operational Management

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
OTC Pet Medicine Market - Global Industry Analysis, Forecast for 2032

OTC Pet Medicine Market - Global Industry Analysis, Forecast for 2032

It is predicted to reach 9.95 billion US dollars in 2025 and grow to 13.27 billion US dollars by 2032.

Fairfield Market Research is a research company that publishes highly relevant market data and insightful detailed reports. The global OTC pet pharmaceuticals market is experiencing significant growth, driven by an increase in pet ownership and substantial advancements in pet healthcare products. Fueled by the rising importance of pet health and wellness, the market is expected to grow at a compound annual growth rate (CAGR) of 4.20% throughout the forecast period. The market size is projected to reach USD 9.95 billion by 2025, with further growth anticipated to USD 13.27 billion by 2032. This growth underscores the trend of pets increasingly being regarded as family members and the deepening bond between humans and pets. This report provides a detailed analysis of the OTC pet pharmaceuticals market. It analyzes the market by product type, pet type, pharmaceutical form, and sales channel, and also discusses the strategies and challenges of key market players in detail.

  • others
  • others

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Pharmaceutical Products in Genetic Engineering

[Research Material] The Global Market for Pharmaceutical Products in Genetic Engineering

World Market for Genetic Engineering Pharmaceuticals: Monoclonal Antibodies, Recombinant Human Erythropoietin, Recombinant Human Interferon, Recombinant Human Growth ...

This research report (Global Genetic Engineering Drug Market) investigates and analyzes the current status and outlook for the global market of genetic engineering pharmaceuticals over the next five years. It includes information on the overview of the global genetic engineering pharmaceuticals market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the genetic engineering pharmaceuticals market focus on monoclonal antibodies, recombinant human erythropoietin, recombinant human interferon, recombinant human growth hormone, and recombinant human insulin, while the segments by application cover medical, research, industrial, agricultural, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for genetic engineering pharmaceuticals. The report also includes the market share of major companies in genetic engineering pharmaceuticals, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Pharmaceutical Products

[Research Material] Global Market for Pharmaceutical Products

World Market for Prescription Pharmaceuticals: Lipid Regulators, Narcotic Analgesics, ACE Inhibitors, Respiratory Agents, Diuretics, Calcium Channel Blockers, Hormonal Contraceptives, and others...

This research report (Global Ethical Pharmaceuticals Market) investigates and analyzes the current state of the global market for prescription pharmaceuticals and its outlook for the next five years. It includes information on the overview of the global prescription pharmaceuticals market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the prescription pharmaceuticals market include lipid regulators, narcotic analgesics, ACE inhibitors, respiratory agents, diuretics, calcium channel blockers, hormonal contraceptives, and others. The segments by application focus on hospitals and clinics, pharmaceutical companies, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for prescription pharmaceuticals. It also includes the market share of major companies in the prescription pharmaceuticals sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
The global market for recombinant human erythropoietin (rhEPO)

The global market for recombinant human erythropoietin (rhEPO)

World Market for Recombinant Human Erythropoietin (rhEPO): ESRD, Cancer, HIV, Wound & Neurological Diseases, Hospitals, Retail Pharmacies

This research report (Global Recombinant Human Erythropoietin (rhEPO) Market) investigates and analyzes the current status and outlook for the global market of recombinant human erythropoietin (rhEPO) over the next five years. It includes information on the global recombinant human erythropoietin (rhEPO) market overview, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for recombinant human erythropoietin (rhEPO) by type target ESRD, cancer, HIV, and wound/neuro diseases, while the segments by application focus on hospitals and retail pharmacies. The regional segments calculate the market size of recombinant human erythropoietin (rhEPO) by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in recombinant human erythropoietin (rhEPO), product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Prescription Drugs

[Research Material] The Global Market for Prescription Drugs

World Market for Prescription Pharmaceuticals: PIA, PAA, CUPM, PDA, SAPM, Consumers under 18, Consumers aged 19-44, Consumers aged 45-64 ...

This research report (Global Compounding Pharmacy Market) investigates and analyzes the current state of the global compounding pharmacy market and its outlook for the next five years. It includes information on the overview of the global compounding pharmacy market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the compounding pharmacy market focus on PIA, PAA, CUPM, PDA, and SAPM, while the segments by application target consumers under 18 years old, consumers aged 19-44, consumers aged 45-64, and consumers aged 65 and older. The regional segments calculate the market size of compounding pharmacies by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the compounding pharmacy sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.